Ares Capital Corporation, a prominent business development company in the United States, recently filed a Form 40-33 with the U.S. Securities and Exchange Commission (SEC) on August 21, 2026. This filing pertains to stockholder derivative actions under Section 33 of the Investment Company Act of 1940. The submission indicates that Ares Capital has received and processed documentation related to shareholder claims, a routine aspect of regulatory compliance for investment companies.
Ares Capital, headquartered in New York, operates within the financial sector, specifically focusing on capital markets. The company is involved in a range of financial activities, including acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions targeting middle market companies. Additionally, it provides growth capital and general refinancing services.
The company is publicly traded on the Nasdaq stock exchange, with its shares priced at $19.92 as of August 20, 2026. Over the past year, Ares Capital’s stock has experienced fluctuations, reaching a 52-week high of $22.51 on September 7, 2025, and a low of $17.40 on March 26, 2026. The company’s market capitalization stands at approximately $14.3 billion, with a price-to-earnings ratio of 14.83.
Ares Capital Corporation was initially established through a public offering on October 6, 2004. For further details on its operations and services, interested parties can visit the company’s website at www.arescapitalcorp.com .
The recent SEC filing, conducted at the company’s New York office, is part of the ongoing regulatory reporting obligations that investment companies must adhere to. While the filing addresses shareholder claims, it does not include additional financial or operational disclosures. This transparency is a standard practice aimed at maintaining investor confidence and regulatory compliance.
